Abstract:B cell activating factor from the TNF family (BAFF) is implicated in not only the physiology of normal B cells, but also the pathophysiology of aggressive B cells related to malignant and autoimmune diseases. Autophagy plays a crucial role in balancing the beneficial and detrimental effects of immunity and inflammation. However, little is known about whether and how excessive BAFF mediates autophagy contributing to B-cell proliferation and survival. Here, we show that excessive human soluble BAFF (hsBAFF) inhibited autophagy with a concomitant reduction of LC3-II in normal and B-lymphoid (Raji) cells. Knockdown of LC3 not only potentiated hsBAFF inhibition of autophagy, but also attenuated hsBAFF activation of Akt/mTOR pathway, thereby diminishing hsBAFF-induced B-cell proliferation/viability. Further, we found that hsBAFF inhibition of autophagy was Akt/mTOR-dependent. This is supported by the findings that hsBAFF increased mTORC1-mediated phosphorylation of ULK1 (Ser757); Akt inhibitor X, mTORC1 inhibitor rapamycin, mTORC1/2 inhibitor PP242, expression of dominant negative Akt, or knockdown of mTOR attenuated hsBAFF-induced phosphorylation of ULK1, decrease of LC3-II level, and increase of cell proliferation/viability. Chelating intracellular free Ca2+ ([Ca2+]i) with BAPTA/AM or preventing [Ca2+]i elevation using EGTA or 2-APB profoundly blocked hsBAFF-induced activation of Akt/mTOR, phosphorylation of ULK1 and decrease of LC3-II, as well as increase of cell proliferation/viability. Similar effects were observed in the cells where CaMKII was inhibited by KN93 or knocked down by CaMKII shRNA. Collectively, these results indicate that hsBAFF inhibits autophagy promoting cell proliferation and survival through activating Ca2+-CaMKII-dependent Akt/mTOR signaling pathway in normal and neoplastic B-lymphoid cells. Our findings suggest that manipulation of intracellular Ca2+ level or CaMKII, Akt, or mTOR activity to promote autophagy may be exploited for prevention of excessive BAFF-induced aggressive B lymphocyte disorders and autoimmune diseases.

BAFF activates Erk1/2 promoting cell proliferation and survival by Ca 2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells

BAFF Inhibits Autophagy Promoting Cell Proliferation and Survival by Activating Ca2+-CaMKII-dependent Akt/mTOR Signaling Pathway in Normal and Neoplastic B-lymphoid Cells.

Hsbaff Promotes Proliferation and Survival in Cultured B Lymphocytes Via Calcium Signaling Activation of Mtor Pathway

IL-2, IL-4, IFN-γ or TNF-α Enhances BAFF-stimulated Cell Viability and Survival by Activating Erk1/2 and S6K1 Pathways in Neoplastic B-lymphoid Cells

Hsbaff-Upregulated Intracellular Free Ca2+ Homeostasis Regulates Erk1/2 Activity and Cell Proliferation in B Cells in Vitro

HsBAFF regulates proliferation and response in cultured CD4+ T lymphocytes by upregulation of intracellular free Ca2+ homeostasis

BAFF Promotes FLS Activation Through BAFFR-Mediated Non-canonical NF-κB Pathway and the Effects of CP-25.

BST-2/Tetherin is involved in BAFF-enhanced proliferation and survival via canonical NF-κB signaling in neoplastic B-lymphoid cells

BAFF promotes follicular helper T cell development and germinal center formation through BR3 signal

BAFF Binding to T Cell-Expressed BAFF-R Promotes Follicular Helper T Cell Proliferation and GC B Cell Responses

BAFF-driven NLRP3 inflammasome activation in B cells

The Function of BAFF on T Helper Cells in Autoimmunity.

Rapamycin Inhibits B-cell Activating Factor (Baff)-Stimulated Cell Proliferation and Survival by Suppressing Ca2+-CaMKII-dependent PTEN/Akt-Erk1/2 Signaling Pathway in Normal and Neoplastic B-lymphoid Cells.

BAFF overexpression in triple-negative breast cancer promotes tumor growth by inducing IL-10-secreting regulatory B cells that suppress anti-tumor T cell responses

hsBAFF enhances activity of NK cells by regulation of CD4+ T lymphocyte function

Rapamycin Inhibits BAFF-stimulated Cell Proliferation and Survival by Suppressing Mtor-Mediated PP2A-Erk1/2 Signaling Pathway in Normal and Neoplastic B-lymphoid Cells.

Rapamycin Attenuates BAFF‐extended Proliferation and Survival Via Disruption of Mtorc1/2 Signaling in Normal and Neoplastic B‐lymphoid Cells

The Role BAFF and BAFF Receptors in Macrophage Induced Drug Resistance of Multiple Myeloma

BAFFR activates PI3K/AKT signaling in human naive but not in switched memory B cells through direct interactions with B cell antigen receptors

Current status of BAFF targeting immunotherapy in B-cell neoplasm

BAFF Induces Spleen CD4+ T Cell Proliferation by Down-Regulating Phosphorylation of FOXO3A and Activates Cyclin D2 and D3 Expression